These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 9514638)
1. Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia. Alexander JE; Berry AM; Paton JC; Rubins JB; Andrew PW; Mitchell TJ Microb Pathog; 1998 Mar; 24(3):167-74. PubMed ID: 9514638 [TBL] [Abstract][Full Text] [Related]
2. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. Rubins JB; Charboneau D; Paton JC; Mitchell TJ; Andrew PW; Janoff EN J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608 [TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci. Dessing MC; Florquin S; Paton JC; van der Poll T Cell Microbiol; 2008 Jan; 10(1):237-46. PubMed ID: 17711480 [TBL] [Abstract][Full Text] [Related]
4. Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin. Jounblat R; Kadioglu A; Mitchell TJ; Andrew PW Infect Immun; 2003 Apr; 71(4):1813-9. PubMed ID: 12654795 [TBL] [Abstract][Full Text] [Related]
5. Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene. Berry AM; Ogunniyi AD; Miller DC; Paton JC Infect Immun; 1999 Feb; 67(2):981-5. PubMed ID: 9916120 [TBL] [Abstract][Full Text] [Related]
6. Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae. Berry AM; Alexander JE; Mitchell TJ; Andrew PW; Hansman D; Paton JC Infect Immun; 1995 May; 63(5):1969-74. PubMed ID: 7729909 [TBL] [Abstract][Full Text] [Related]
7. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. Orihuela CJ; Gao G; Francis KP; Yu J; Tuomanen EI J Infect Dis; 2004 Nov; 190(9):1661-9. PubMed ID: 15478073 [TBL] [Abstract][Full Text] [Related]
8. Sequence variation in the Streptococcus pneumoniae pneumolysin gene affecting haemolytic activity and electrophoretic mobility of the toxin. Lock RA; Zhang QY; Berry AM; Paton JC Microb Pathog; 1996 Aug; 21(2):71-83. PubMed ID: 8844651 [TBL] [Abstract][Full Text] [Related]
9. The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model. Benton KA; Paton JC; Briles DE Microb Pathog; 1997 Oct; 23(4):201-9. PubMed ID: 9344781 [TBL] [Abstract][Full Text] [Related]
10. Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Rubins JB; Charboneau D; Fasching C; Berry AM; Paton JC; Alexander JE; Andrew PW; Mitchell TJ; Janoff EN Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1339-46. PubMed ID: 8616564 [TBL] [Abstract][Full Text] [Related]
11. The contribution of PspC to pneumococcal virulence varies between strains and is accomplished by both complement evasion and complement-independent mechanisms. Kerr AR; Paterson GK; McCluskey J; Iannelli F; Oggioni MR; Pozzi G; Mitchell TJ Infect Immun; 2006 Sep; 74(9):5319-24. PubMed ID: 16926426 [TBL] [Abstract][Full Text] [Related]
12. Site-specific contributions of glutamine-dependent regulator GlnR and GlnR-regulated genes to virulence of Streptococcus pneumoniae. Hendriksen WT; Kloosterman TG; Bootsma HJ; Estevão S; de Groot R; Kuipers OP; Hermans PW Infect Immun; 2008 Mar; 76(3):1230-8. PubMed ID: 18174343 [TBL] [Abstract][Full Text] [Related]
13. Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model. Ogunniyi AD; LeMessurier KS; Graham RM; Watt JM; Briles DE; Stroeher UH; Paton JC Infect Immun; 2007 Apr; 75(4):1843-51. PubMed ID: 17261599 [TBL] [Abstract][Full Text] [Related]
14. Streptococcus pneumoniae deficient in pneumolysin or autolysin has reduced virulence in meningitis. Hirst RA; Gosai B; Rutman A; Guerin CJ; Nicotera P; Andrew PW; O'Callaghan C J Infect Dis; 2008 Mar; 197(5):744-51. PubMed ID: 18260758 [TBL] [Abstract][Full Text] [Related]
15. Studies on the structure and mechanism of a bacterial protein toxin by analytical ultracentrifugation and small-angle neutron scattering. Gilbert RJ; Heenan RK; Timmins PA; Gingles NA; Mitchell TJ; Rowe AJ; Rossjohn J; Parker MW; Andrew PW; Byron O J Mol Biol; 1999 Nov; 293(5):1145-60. PubMed ID: 10547292 [TBL] [Abstract][Full Text] [Related]
16. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines. Kirkham LA; Kerr AR; Douce GR; Paterson GK; Dilts DA; Liu DF; Mitchell TJ Infect Immun; 2006 Jan; 74(1):586-93. PubMed ID: 16369015 [TBL] [Abstract][Full Text] [Related]
17. Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin. García-Suárez Mdel M; Cima-Cabal MD; Flórez N; García P; Cernuda-Cernuda R; Astudillo A; Vázquez F; De los Toyos JR; Méndez FJ Infect Immun; 2004 Aug; 72(8):4534-40. PubMed ID: 15271913 [TBL] [Abstract][Full Text] [Related]
18. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. Briles DE; Hollingshead SK; Paton JC; Ades EW; Novak L; van Ginkel FW; Benjamin WH J Infect Dis; 2003 Aug; 188(3):339-48. PubMed ID: 12870114 [TBL] [Abstract][Full Text] [Related]
19. Biological properties of pneumolysin. Mitchell TJ; Andrew PW Microb Drug Resist; 1997; 3(1):19-26. PubMed ID: 9109093 [TBL] [Abstract][Full Text] [Related]
20. Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia. Witzenrath M; Gutbier B; Hocke AC; Schmeck B; Hippenstiel S; Berger K; Mitchell TJ; de los Toyos JR; Rosseau S; Suttorp N; Schütte H Crit Care Med; 2006 Jul; 34(7):1947-54. PubMed ID: 16715037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]